Testicular cancer

Testicular cancer is the most common tumour among men aged between 15 and 35 years, and represents 1% of all cancers diagnosed in men.

Fortunately, the vast majority of patients are cured, even in cases where the disease is advanced. The principal risk factor is cryptorchidism, meaning failure of the testicle to descend at birth.

The function of a centre like Onkologikoa is to provide a cure, and part of this process, almost equally as important as the treatment, is the way the patient is treated. Duly informing them, accompanying them… All in the endeavour to achieve a positive outcome, over and above our prestigious team of professionals.

information of interest

AEU

AUE

American Urological Association

NCCN

Instituto Nacional de Cáncer

Call us if you prefer 0034943328000

Treatments for this kind of cancer

Surgery

The treatment of testicular tumours first of all requires removal of the testicle by means of a surgical operation known as oriechtomy. This is one of the few tumours where, even if the disease has spread to other organs, the original tumour must be removed, since its examination is highly important for establishing its characteristics and treatment. Once the testicle has been removed, the treatment is decided according to the type of tumour, its extension and its prognostic category.

Stage I

Complementary treatment

These tumours only affect the testicle, meaning that, in theory, its removal should be sufficient to cure the cancer. The problem is that the disease may reappear in a small percentage of patients. To prevent this from happening, in some case complementary treatment can also be administered for preventive purposes (adjuvant treatment). Seminoma.

Stage I

Chemotherapy

If the tumour reappears, it is advisable to administer chemotherapy with 1 or 2 cycles of carboplatin. Non-seminoma.

Stage I

Preventive chemotherapy - Two cycles of BEP

Patients whose tumour invades the blood or lymphatic vessels of the testicle are at greater risk of the disease reappearing. In this case it would be justifiable to administer preventive chemotherapy with two cycles of BEP (Bleomycin, Etoposide, Cisplatin).

Stage II

Chemotherapy with 3 cycles of BEP

Patients at this stage have the disease in the retroperitoneal lymph nodes. The majority of cases can be cured with adequate treatment. Seminoma.

The usual treatment in these patients consists of chemotherapy with 3 cycles of BEP. In some patients, lymphatic node remains are left in the retroperitoneal space after these treatments.

Stage III

Chemotherapy with 3 cycles of BEP

The treatment in these patients is similar for both non-seminoma and seminoma tumours, and will be decided depending on the risk group to which they belong.
Patients with a favourable prognosis. Three cycles of BEP.

Stage III

Chemotherapy with 4 cycles of BEP

The treatment in these patients is similar for both non-seminoma and seminoma tumours, and will be decided depending on the risk group to which they belong.
Patients with an intermediate or unfavourable prognosis. Four cycles of BEP.